225 related articles for article (PubMed ID: 7869773)
1. Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2.
Abe A; Emi N; Kato H; Adachi K; Murate T; Saga S; Ogura M; Kojima T; Tanimoto M; Morishita N
Leukemia; 1995 Feb; 9(2):341-9. PubMed ID: 7869773
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival.
Komatsu N; Nakauchi H; Miwa A; Ishihara T; Eguchi M; Moroi M; Okada M; Sato Y; Wada H; Yawata Y
Cancer Res; 1991 Jan; 51(1):341-8. PubMed ID: 1824823
[TBL] [Abstract][Full Text] [Related]
3. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K
Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a human megakaryoblastic cell line (T-33) from chronic myelogenous leukemia in megakaryoblastic crisis.
Tange T; Nakahara K; Mitani K; Yamasaki I; Yasuda H; Tanaka F; Mizuguchi M; Oda H; Yatomi Y; Takanashi R
Cancer Res; 1988 Nov; 48(21):6137-44. PubMed ID: 3167860
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a novel human monocytic leukemia cell line (KP-1) expressing scavenger receptor.
Adachi N; Takaki K; Nakamura R; Ohta T; Naito M; Horiuchi S; Matsuda I
Pediatr Res; 1993 Sep; 34(3):258-64. PubMed ID: 8134164
[TBL] [Abstract][Full Text] [Related]
6. Expression of megakaryocytic and erythroid properties in human leukemic cells.
Tani T; Ylänne J; Virtanen I
Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a novel human immature megakaryoblastic leukemia cell line, M-MOK, dependent on fibroblasts for its viability.
Itano M; Tsuchiya S; Minegishi N; Fujie H; Minegishi M; Morita S; Yambe T; Ohashi Y; Masuda T; Koike T
Exp Hematol; 1995 Nov; 23(12):1301-9. PubMed ID: 7589286
[TBL] [Abstract][Full Text] [Related]
8. A novel Philadelphia chromosome-positive cell line with multipotential properties.
Nakayama T; Tohyama K; Imamura S; Yoshida A; Fukushima T; Tsutani H; Nakamura T; Wano Y; Ohno Y; Ueda T
Anticancer Res; 1999; 19(1A):349-56. PubMed ID: 10226566
[TBL] [Abstract][Full Text] [Related]
9. Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors.
Gore SD; Amin S; Weng LJ; Civin CI
Exp Hematol; 1995 May; 23(5):413-21. PubMed ID: 7536683
[TBL] [Abstract][Full Text] [Related]
10. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
11. A novel CD10-positive erythroid cell line, RM10, established from a patient with chronic myelogenous leukemia.
Hirata J; Sato H; Takahira H; Shiokawa S; Endo T; Nishimura J; Katsuno M; Masuda S; Sasaki R; Fukumaki Y
Leukemia; 1990 May; 4(5):365-72. PubMed ID: 2167410
[TBL] [Abstract][Full Text] [Related]
12. MEG-01s cells have receptors for and respond to IL-3, IL-6, and SCF.
Kellar KL; Hooper WC; Benson JM
Exp Hematol; 1995 Jun; 23(6):557-64. PubMed ID: 7539384
[TBL] [Abstract][Full Text] [Related]
13. IL-2 inhibits proliferation of K562 cells and reduces accumulation of bcr/abl mRNA and oncoprotein.
Dilloo D; Hanenberg H; Lion T; Burdach S
Leukemia; 1995 Mar; 9(3):419-24. PubMed ID: 7885040
[TBL] [Abstract][Full Text] [Related]
14. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
[TBL] [Abstract][Full Text] [Related]
15. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M
Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
[TBL] [Abstract][Full Text] [Related]
16. Expression of prostacyclin receptor in human megakaryocytes.
Sasaki Y; Takahashi T; Tanaka I; Nakamura K; Okuno Y; Nakagawa O; Narumiya S; Nakao K
Blood; 1997 Aug; 90(3):1039-46. PubMed ID: 9242534
[TBL] [Abstract][Full Text] [Related]
17. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
18. Cellular characteristics of chronic myelocytic leukemia basophilic crisis cells: phenotype, responsiveness to and receptor gene expression for various kinds of growth factors and cytokines.
Shimizu N; Kita K; Masuya M; Nishii K; Matsuoka N; Morita N; Miwa H; Shirakawa S
Exp Hematol; 1993 Jan; 21(1):119-25. PubMed ID: 7678084
[TBL] [Abstract][Full Text] [Related]
19. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
[TBL] [Abstract][Full Text] [Related]
20. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]